Aligos Therapeutics Presents Positive Data at APASL 2025
Detailed price information for Aligos Therapeutics Inc (ALGS-Q) from The Globe and Mail including charting and trades.
Yahoo Finance6d
Aligos Therapeutics Presents Positive Data at APASL 2025
Aligos Therapeutics SOUTH SAN FRANCISCO, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on ...
A Path to a Healthier Future With Chronic Hepatitis B Virus Infection
Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class ...
Aligos Therapeutics files to sell 6.25M shares of common stock for holders
EDT Aligos Therapeutics (ALGS) files to sell 6.25M shares of common stock for holdersLight Up your Portfolio with Spark:Easily identify ...
Morningstar6d
Aligos Therapeutics Presents Positive Data at APASL 2025
SOUTH SAN FRANCISCO, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel ...
Mena FN6d
Aligos Therapeutics Presents Positive Data At APASL 2025
(MENAFN- GlobeNewsWire - Nasdaq) SOUTH SAN FRANCISCO, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS,“Aligos”), a clinical ...
Yahoo Finance4d
Aligos Therapeutics, Inc. (ALGS)
SOUTH SAN FRANCISCO, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics ...
Strengthening Communities: A Campaign Dedicated To Fighting Infectious Diseases
Despite remarkable advancements in modern medicine, infectious diseases remain a global challenge, impacting millions each year. From emerging threat ...